Affiliation:
1. GPST3, Pinfold Surgery, Health Care First, Leeds
2. Email: Twitter handle: @pkgharial
Abstract
Haemoglobinopathies are inherited disorders of the globin component of haemoglobin. Genetic mutations lead to an altered structure of haemoglobin, as in sickle cell disease, or reduced quantity of haemoglobin, as in thalassaemia. Significant haemoglobinopathies are usually detected shortly after birth. Milder forms can present later in life, with anaemia or other complications, which is why it is important for GPs to have an understanding of haemoglobinopathies. The purpose of this article is to provide an overview of the two most significant clinical haemoglobinopathies, sickle cell disease and thalassaemia, and to focus on their primary care management.
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference12 articles.
1. Bain BJ (2020) Haematology: A Core Curriculum. World Scientific Publishing Europe Ltd.
2. Chonat S and Quinn CT (2017) Current standards of care and long term outcomes for thalassemia and sickle cell disease. In: Malik P and Tisdale J (eds) Gene and Cell Therapies for Beta-Globinopathies. Advances in Experimental Medicine and Biology: 1013. New York, NY: Springer. DOI: 10.1007/978-1-4939-7299-9_3.
3. Hillman RS, Ault KA, Leporrier M, et al. (2011) Haematology in Clinical Practice. The McGraw-Hill Companies, Inc.
4. NICE (2021) Clinical knowledge summary. Sickle cell disease. Available at: https://cks.nice.org.uk/topics/sickle-cell-disease/ (accessed 16 October 2021).
5. Public Health England (2018a) Understanding haemoglobinopathies. Available at: www.gov.uk/government/publications/handbook-for-sickle-cell-and-thalassaemia-screening/understanding-haemoglobinopathies#inheritance-of-haemoglobinopathies (accessed 5 July 2021).